<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Dicerna Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The Company is using its proprietary GalXC RNAi technology platform to build a broad pipeline in these therapeutic areas. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $188,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas M. Fambrough, III, Ph.D.
    • FOUNDED
      2007
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    NantKwest, Inc.

    NantKwest, Inc.

    NantKwest is an innovative clinical-stage immunotherapy company focused on harness...

    NantKwest is an innovative clinical-stage immun...

    Filing Type:    PU
    Global Blood Therapeutics, Inc.

    Global Blood Therapeutics, Inc.

    Global Blood Therapeutics, Inc. (GBT) is a clinical-stage biopharmaceutical dedica...

    Global Blood Therapeutics, Inc. (GBT) is a clin...

    Filing Type:    PU
    Kamada Ltd.

    Kamada Ltd.

    Kamada Ltd. is focused on plasma-derived protein therapeutics for orphan indicatio...

    Kamada Ltd. is focused on plasma-derived protei...

    Filing Type:    PU
    Cytokinetics, Incorporated

    Cytokinetics, Incorporated

    Cytokinetics is a late-stage biopharmaceutical company focused on discovering, dev...

    Cytokinetics is a late-stage biopharmaceutical ...

    Filing Type:    PU
    Eyegate Pharmaceuticals, Inc.

    Eyegate Pharmaceuticals, Inc.

    EyeGate is developing and commercializing products for treating diseases and disor...

    EyeGate is developing and commercializing produ...

    Filing Type:    PU
    Protagonist Therapeutics, Inc.

    Protagonist Therapeutics, Inc.

    Protagonist Therapeutics is a clinical stage biopharmaceutical company that utiliz...

    Protagonist Therapeutics is a clinical stage bi...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Madrigal Pharmaceuticals, Inc.

    Madrigal Pharmaceuticals, Inc.

    Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing no...

    Madrigal Pharmaceuticals is a clinical-stage bi...

    Filing Type:    PU
    Cara Therapeutics, Inc.

    Cara Therapeutics, Inc.

    Cara Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Cara Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    AtriCure, Inc.

    AtriCure, Inc.

    As a leading provider of innovative technologies for the treatment of Atrial Fibri...

    As a leading provider of innovative technologie...

    Filing Type:    PU
    Athersys, Inc.

    Athersys, Inc.

    We are an international biotechnology company that is focused in the field of rege...

    We are an international biotechnology company t...

    Filing Type:    PU
    The Medicines Company

    The Medicines Company

    The Medicines Company is a biopharmaceutical company driven by an overriding purpo...

    The Medicines Company is a biopharmaceutical co...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.